日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Order of treatment with ALK inhibitors and its effect on people with lung cancer in the real world: a plain language summary

ALK抑制剂治疗顺序及其对肺癌患者真实世界影响:简明语言概述

Bauman, Jessica R; Liu, Geoffrey; Preeshagul, Isabel; Melosky, Barbara; Abrahami, Devin; Li, Benjamin; Thomaidou, Despina; Krulewicz, Stan; Rupp, Martin

Office-based flexible sigmoidoscopy allows rapid assessment and management of suspected immune checkpoint inhibitor-related colitis

门诊柔性乙状结肠镜检查可快速评估和处理疑似免疫检查点抑制剂相关性结肠炎。

Siev, Alana; Livingstone, Pamela; Tom, Erika; Corso, Tara; Preeshagul, Isabel; Postow, Michael; Shah, Neil J; Niec, Rachel; Schattner, Mark; Faleck, David M

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

一项开放标签、随机、对照的II期研究,旨在评估标准全身治疗联合或不联合立体定向放射治疗对寡转移进展型乳腺癌或非小细胞肺癌患者的疗效(巩固性放射治疗阻断寡转移进展[CURB]):一项研究。

Tsai, Chiaojung Jillian; Yang, Jonathan T; Shaverdian, Narek; Patel, Juber; Shepherd, Annemarie F; Eng, Juliana; Guttmann, David; Yeh, Randy; Gelblum, Daphna Y; Namakydoust, Azadeh; Preeshagul, Isabel; Modi, Shanu; Seidman, Andrew; Traina, Tiffany; Drullinsky, Pamela; Flynn, Jessica; Zhang, Zhigang; Rimner, Andreas; Gillespie, Erin F; Gomez, Daniel R; Lee, Nancy Y; Berger, Michael; Robson, Mark E; Reis-Filho, Jorge S; Riaz, Nadeem; Rudin, Charles M; Powell, Simon N

A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer

Valemetostat (DS-3201b)(一种 EZH1/2 抑制剂)联合伊立替康治疗复发性小细胞肺癌患者的 I/II 期研究

Choudhury, Noura J; Lai, W Victoria; Makhnin, Alex; Heller, Glenn; Eng, Juliana; Li, Bob; Preeshagul, Isabel; Santini, Fernando C; Offin, Michael; Ng, Kenneth; Paik, Paul; Larsen, Christina; Ginsberg, Michelle S; Lau, Yvonne; Zhang, Xinyuan; Baine, Marina K; Rekhtman, Natasha; Rudin, Charles M

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

探索已发表的和新型的治疗前CT和PET放射组学数据,以对接受立体定向放射治疗的早期非小细胞肺癌患者的疾病进展风险进行分层

Thor, Maria; Fitzgerald, Kelly; Apte, Aditya; Oh, Jung Hun; Iyer, Aditi; Odiase, Otasowie; Nadeem, Saad; Yorke, Ellen D; Chaft, Jamie; Wu, Abraham J; Offin, Michael; Simone II, Charles B; Preeshagul, Isabel; Gelblum, Daphna Y; Gomez, Daniel; Deasy, Joseph O; Rimner, Andreas

Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer

ALK阳性晚期非小细胞肺癌患者第二代和第三代ALK酪氨酸激酶抑制剂的真实世界治疗顺序和疗效

Bauman, Jessica R; Liu, Geoffrey; Preeshagul, Isabel; Liu, Stephen V; Melosky, Barbara; Abrahami, Devin; Li, Benjamin; Thomaidou, Despina; Duncan, Kirsten; Krulewicz, Stan; Rupp, Martin; Lin, Jessica J

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study

PD-(L)1阻断单药治疗与PD-(L)1阻断联合化疗一线治疗PD-L1阳性晚期肺腺癌的疗效比较:一项队列研究

Elkrief, Arielle; Alessi, Joao M Victor; Ricciuti, Biagio; Brown, Samantha; Rizvi, Hira; Preeshagul, Isabel R; Wang, Xinan; Pecci, Federica; Di Federico, Alessandro; Lamberti, Giuseppe; Egger, Jacklynn V; Chaft, Jamie E; Rudin, Charles M; Riely, Gregory J; Kris, Mark G; Ladanyi, Marc; Chen, Yuan; Hellmann, Matthew D; Shen, Ronglai; Awad, Mark M; Schoenfeld, Adam J

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

简报:奥希替尼联合达可替尼治疗EGFR突变型肺腺癌的原发性和获得性耐药

Elkrief, Arielle; Makhnin, Alex; Moses, Khadeja A; Ahn, Linda S; Preeshagul, Isabel R; Iqbal, Afsheen N; Hayes, Sara A; Plodkowski, Andrew J; Paik, Paul K; Ladanyi, Marc; Kris, Mark G; Riely, Gregory J; Michor, Franziska; Yu, Helena A

Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer

在真实世界队列中,Sotorasib治疗晚期KRAS G12C突变型非小细胞肺癌患者的临床和基因组学特征及其疗效和毒性

Thummalapalli, Rohit; Bernstein, Ezra; Herzberg, Benjamin; Li, Bob T; Iqbal, Afsheen; Preeshagul, Isabel; Santini, Fernando C; Eng, Juliana; Ladanyi, Marc; Yang, Soo-Ryum; Shen, Ronglai; Lito, Piro; Riely, Gregory J; Sabari, Joshua K; Arbour, Kathryn C

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

循环肿瘤DNA指导治疗晚期非小细胞肺癌的总体生存率

Jee, Justin; Lebow, Emily S; Yeh, Randy; Das, Jeeban P; Namakydoust, Azadeh; Paik, Paul K; Chaft, Jamie E; Jayakumaran, Gowtham; Rose Brannon, A; Benayed, Ryma; Zehir, Ahmet; Donoghue, Mark; Schultz, Nikolaus; Chakravarty, Debyani; Kundra, Ritika; Madupuri, Ramyasree; Murciano-Goroff, Yonina R; Tu, Hai-Yan; Xu, Chong-Rui; Martinez, Andrés; Wilhelm, Clare; Galle, Jesse; Daly, Bobby; Yu, Helena A; Offin, Michael; Hellmann, Matthew D; Lito, Piro; Arbour, Kathryn C; Zauderer, Marjorie G; Kris, Mark G; Ng, Kenneth K; Eng, Juliana; Preeshagul, Isabel; Victoria Lai, W; Fiore, John J; Iqbal, Afsheen; Molena, Daniela; Rocco, Gaetano; Park, Bernard J; Lim, Lee P; Li, Mark; Tong-Li, Candace; De Silva, Madhawa; Chan, David L; Diakos, Connie I; Itchins, Malinda; Clarke, Stephen; Pavlakis, Nick; Lee, Adrian; Rekhtman, Natasha; Chang, Jason; Travis, William D; Riely, Gregory J; Solit, David B; Gonen, Mithat; Rusch, Valerie W; Rimner, Andreas; Gomez, Daniel; Drilon, Alexander; Scher, Howard I; Shah, Sohrab P; Berger, Michael F; Arcila, Maria E; Ladanyi, Marc; Levine, Ross L; Shen, Ronglai; Razavi, Pedram; Reis-Filho, Jorge S; Jones, David R; Rudin, Charles M; Isbell, James M; Li, Bob T